August 1, 2022
Via: medicaldevice-network.comThe US Food and Drug Administration (FDA) has re-authorised the emergency use authorization (EUA) for Meridian Bioscience’s Revogene SARS-CoV-2 molecular assay. The regulator initially granted EUA for the Covid-19 molecular diagnostic test last November. However, the company decided to delay […]
May 19, 2023